References
- Mu, J.; Lin, J.; Huang, P.; Chen, X. Development of Endogenous Enzyme-Responsive Nanomaterials for Theranostics. Chem. Soc. Rev. 2018, 47, 5554–5573. DOI: https://doi.org/10.1039/C7CS00663B.
- Chen, H.; Liu, D.; Guo, Z. Endogenous Stimuli-Responsive Nanocarriers for Drug Delivery. Chem. Lett. 2016, 45, 242–249. DOI: https://doi.org/10.1246/cl.151176.
- Ahmed, N.; Fessi, H.; Elaissari, A. Theranostic Applications of Nanoparticles in Cancer. Drug Discov. Today. 2012, 17, 928–934. DOI: https://doi.org/10.1016/j.drudis.2012.03.010.
- Sahle, F. F.; Gulfam, M.; Lowe, T. L. Design Strategies for Physical-Stimuli-Responsive Programmable Nanotherapeutics. Drug Discov. Today. 2018, 23, 992–1006. DOI: https://doi.org/10.1016/j.drudis.2018.04.003.
- Gulfam, M.; Sahle, F. F.; Lowe, T. L. Design Strategies for Chemical-Stimuli-Responsive Programmable Nanotherapeutics. Drug Discov. Today. 2019, 24, 129–147. DOI: https://doi.org/10.1016/j.drudis.2018.09.019.
- Liu, D.; Yang, F.; Xiong, F.; Gu, N. The Smart Drug Delivery System and Its Clinical Potential. Theranostics. 2016, 6, 1306–1323. DOI: https://doi.org/10.7150/thno.14858.
- Xiao, W.; Zeng, X.; Lin, H.; Han, K.; Jia, H.-Z.; Zhang, X.-Z. Dual Stimuli-Responsive Multi-Drug Delivery System for the Individually Controlled Release of Anti-Cancer Drugs. ChemComm. 2015, 51, 1475–1478.
- Cai, W.; Wang, J.; Chu, C.; Chen, W.; Wu, C.; Liu, G. Metal-Organic Framework-Based Stimuli-Responsive Systems for Drug Delivery. Adv. Sci. 2019, 6, 1801526. DOI: https://doi.org/10.1002/advs.201801526.
- Hatakeyama, H. Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and Therapeutics. Chem. Pharm. Bull. 2017, 65, 612–617. DOI: https://doi.org/10.1248/cpb.c17-00068.
- Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-Responsive Nanocarriers for Drug Delivery. Nat. Mater. 2013, 12, 991–1003. DOI: https://doi.org/10.1038/nmat3776.
- Liu, M.; Du, H.; Zhang, W.; Zhai, G. Internal Stimuli-Responsive Nanocarriers for Drug Delivery: Design Strategies and Applications. Mater. Sci. Eng. C Mater. Biol. Appl. 2017, 71, 1267–1280. DOI: https://doi.org/10.1016/j.msec.2016.11.030.
- Yao, J.; Feng, J.; Chen, J. External-Stimuli Responsive Systems for Cancer Theranostic. Asian J. Pharm. Sci. 2016, 11, 585–595. DOI: https://doi.org/10.1016/j.ajps.2016.06.001.
- Li, C.; Wang, J.; Wang, Y.; Gao, H.; Wei, G.; Huang, Y.; Yu, H.; Gan, Y.; Wang, Y.; Mei, L.; et al. Recent Progress in Drug Delivery. Acta Pharm. Sin. B. 2019, 9, 1145–1162. DOI: https://doi.org/10.1016/j.apsb.2019.08.003.
- Rabti, A.; Hannachi, A.; Maghraoui-Meherzi, H.; Raouafi, N. Ferrocene-Functionalized Carbon Nanotubes: An Adsorbent for Rhodamine B. Chem. Afr. 2019, 2, 113–122. DOI: https://doi.org/10.1007/s42250-018-00031-0.
- Ghassami, E.; Varshosaz, J.; Taymouri, S. Redox Sensitive Polysaccharide Based Nanoparticles for Improved Cancer Treatment: A Comprehensive Review. Curr. Pharm. Des. 2018, 24, 3303–3319. DOI: https://doi.org/10.2174/1381612824666180813114841.
- Gao, S.; Tang, G.; Hua, D.; Xiong, R.; Han, J.; Jiang, S.; Zhang, Q.; Huang, C. Stimuli-Responsive Bio-Based Polymeric Systems and Their Applications. J. Mater. Chem. B. 2019, 7, 709–729. DOI: https://doi.org/10.1039/C8TB02491J.
- Song, Y.; Li, Y.; Xu, Q.; Liu, Z. Mesoporous Silica Nanoparticles for Stimuli-Responsive Controlled Drug Delivery: Advances, Challenges, and Outlook. Int. J. Nanomed. 2017, 12, 87–110.
- Wu, M. X.; Yang, Y. W. Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy. Adv. Mater. 2017, 29, 1606134. DOI: https://doi.org/10.1002/adma.201606134.
- Barve, A.; Jain, A.; Liu, H.; Zhao, Z.; Cheng, K. Enzyme-Responsive Polymeric Micelles of Cabazitaxel for Prostate Cancer Targeted Therapy. Acta Biomater. 2020, 113, 501–511. DOI: https://doi.org/10.1016/j.actbio.2020.06.019.
- Wang, X.; Wang, X.; Jin, S.; Muhammad, N.; Guo, Z. Stimuli-Responsive Therapeutic Metallodrugs. Chem. Rev. 2019, 119, 1138–1192. DOI: https://doi.org/10.1021/acs.chemrev.8b00209.
- El-Sawy, H. S.; Al-Abd, A. M.; Ahmed, T. A.; El-Say, K. M.; Torchilin, V. P. Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives. ACS Nano. 2018, 12, 10636–10664. DOI: https://doi.org/10.1021/acsnano.8b06104.
- Leriche, G.; Chen, A. C.; Kim, S.; Selkoe, D. J.; Yang, J. Fluorescent Analogue of Batimastat Enables Imaging of Α-Secretase in Living Cells. ACS Chem. Neurosci. 2016, 7, 40–45. DOI: https://doi.org/10.1021/acschemneuro.5b00283.
- Ramasamy, T.; Ruttala, H. B.; Gupta, B.; Poudel, B. K.; Choi, H.-G.; Yong, C. S.; Kim, J. O. Smart Chemistry-Based Nanosized Drug Delivery Systems for Systemic Applications: A Comprehensive Review. J. Control. Release. 2017, 258, 226–253. DOI: https://doi.org/10.1016/j.jconrel.2017.04.043.
- Li, Y.; Du, L.; Wu, C.; Yu, B.; Zhang, H.; An, F. Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery. Ctmc. 2019, 19, 74–97. DOI: https://doi.org/10.2174/1568026619666190125144621.
- Zelzer, M.; Todd, S. J.; Hirst, A. R.; McDonald, T. O.; Ulijn, R. V. Enzyme Responsive Materials: Design Strategies and Future Developments. Biomater. Sci. 2013, 1, 11–39. DOI: https://doi.org/10.1039/C2BM00041E.
- Fathi, M.; Safary, A.; Barar, J. Therapeutic Impacts of Enzyme-Responsive Smart Nanobiosystems. Bioimpacts. 2020, 10, 1–4.
- Ruan, S.; Yuan, M.; Zhang, L.; Hu, G.; Chen, J.; Cun, X.; Zhang, Q.; Yang, Y.; He, Q.; Gao, H. Tumor Microenvironment Sensitive Doxorubicin Delivery and Release to Glioma Using Angiopep-2 Decorated Gold Nanoparticles. Biomaterials. 2015, 37, 425–435. DOI: https://doi.org/10.1016/j.biomaterials.2014.10.007.
- Ruan, S.; Cao, X.; Cun, X.; Hu, G.; Zhou, Y.; Zhang, Y.; Lu, L.; He, Q.; Gao, H. Matrix Metalloproteinase-Sensitive Size-Shrinkable Nanoparticles for Deep Tumor Penetration and pH Triggered Doxorubicin Release. Biomaterials. 2015, 60, 100–110. DOI: https://doi.org/10.1016/j.biomaterials.2015.05.006.
- Lu, Y.; Aimetti, A. A.; Langer, R., Gu, Z. Bioresponsive Materials. Nat. Rev. Mater. 2016, 2, 1–17.
- Li, E.; Yang, Y.; Hao, G.; Yi, X.; Zhang, S.; Pan, Y.; Xing, B.; Gao, M. Multifunctional Magnetic Mesoporous Silica Nanoagents for in Vivo Enzyme-Responsive Drug Delivery and MR Imaging. Nanotheranostics. 2018, 2, 233–242. DOI: https://doi.org/10.7150/ntno.25565.
- Yang, H.; Khan, A. R.; Liu, M.; Fu, M.; Ji, J.; Chi, L.; Zhai, G. Stimuli-Responsive Polymeric Micelles for the Delivery of Paclitaxel. J. Drug Deliv. Sci. Technol. 2020, 56, 101523. DOI: https://doi.org/10.1016/j.jddst.2020.101523.
- Kumar, V.; Koyasseril-Yehiya, T. M.; Thayumanavan, S. Enzyme-Triggered Nanomaterials and Their Applications. Mol. Assemblies Charact. Appl. 2020, 7, 95–107. DOI: https://doi.org/10.1021/symposium.
- Blum, A. P.; Kammeyer, J. K.; Rush, A. M.; Callmann, C. E.; Hahn, M. E.; Gianneschi, N. C. Stimuli-Responsive Nanomaterials for Biomedical Applications. J. Am. Chem. Soc. 2015, 137, 2140–2154. DOI: https://doi.org/10.1021/ja510147n.
- Zhou, M.; Wen, K.; Bi, Y.; Lu, H.; Chen, J.; Hu, Y.; Chai, Z. The Application of Stimuli-Responsive Nanocarriers for Targeted Drug Delivery. Curr. Top. Med. Chem. 2017, 17, 2319–2334.
- Conlon, G. A.; Murray, G. I. Recent Advances in Understanding the Roles of Matrix Metalloproteinases in Tumour Invasion and Metastasis. J. Pathol. 2019, 247, 629–640. DOI: https://doi.org/10.1002/path.5225.
- Nagel, G.; Sousa-Herves, A.; Wedepohl, S.; Calderón, M. Matrix Metalloproteinase-Sensitive Multistage Nanogels Promote Drug Transport in 3D Tumor Model. Theranostics. 2020, 10, 91–108. DOI: https://doi.org/10.7150/thno.34851.
- Mumtaz, T.; Qindeel, M.; Tarhini, M.; Ahmed, N.; Elaissari, A. Exploiting Proteases for Cancer Theranostic through Molecular Imaging and Drug Delivery. Int. J. Pharm. 2020, 587, 119712. DOI: https://doi.org/10.1016/j.ijpharm.2020.119712.
- Wang, X.; Gu, M.; Toh, T. B.; Abdullah, N. L. B.; Chow, E. K.-H. Stimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection. SLAS Technol. 2018, 23, 44–56.
- Feng, X.; Chen, Y. Drug Delivery Targets and Systems for Targeted Treatment of Rheumatoid Arthritis. J. Drug Target. 2018, 26, 845–857. DOI: https://doi.org/10.1080/1061186X.2018.1433680.
- Shay, G.; Lynch, C. C.; Fingleton, B. Moving Targets: Emerging Roles for MMPS in Cancer Progression and Metastasis. Matrix Biol. 2015, 44, 200–206.
- Terada, T.; Iwai, M.; Kawakami, S.; Yamashita, F.; Hashida, M. Novel PEG-Matrix Metalloproteinase-2 Cleavable Peptide-Lipid Containing Galactosylated Liposomes for Hepatocellular Carcinoma-Selective Targeting. J. Control. Release. 2006, 111, 333–342. DOI: https://doi.org/10.1016/j.jconrel.2005.12.023.
- Kuang, T.; Liu, Y.; Gong, T.; Peng, X.; Hu, X.; Yu, Z. Enzyme-Responsive Nanoparticles for Anticancer Drug Delivery. Cnano. 2015, 12, 38–46. DOI: https://doi.org/10.2174/1573413711666150624170518.
- Singh, N.; Karambelkar, A.; Gu, L.; Lin, K.; Miller, J. S.; Chen, C. S.; Sailor, M. J.; Bhatia, S. N. Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release. J. Am. Chem. Soc. 2011, 133, 19582–19585. DOI: https://doi.org/10.1021/ja206998x.
- Gao, H.; Zhang, S.; Cao, S.; Yang, Z.; Pang, Z.; Jiang, X. Angiopep-2 and Activatable Cell-Penetrating Peptide Dual-Functionalized Nanoparticles for Systemic Glioma-Targeting Delivery. Mol. Pharm. 2014, 11, 2755–2763. DOI: https://doi.org/10.1021/mp500113p.
- Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor Imaging by means of Proteolytic Activation of Cell-Penetrating Peptides. Proc. Natl. Acad. Sci. USA. 2004, 101, 17867–17872. DOI: https://doi.org/10.1073/pnas.0408191101.
- Hu, Q.; Katti, P. S.; Gu, Z. Enzyme-Responsive Nanomaterials for Controlled Drug Delivery. Nanoscale. 2014, 6, 12273–12286. DOI: https://doi.org/10.1039/C4NR04249B.
- Shao, M.; Yang, W.; Han, G. Protective Effects on Myocardial Infarction Model: Delivery of Schisandrin B Using Matrix Metalloproteinase-Sensitive Peptide-Modified, Pegylated Lipid Nanoparticles. Int. J. Nanomedicine. 2017, 12, 7121–7130. DOI: https://doi.org/10.2147/IJN.S141549.
- Nguyen, J.; Sievers, R.; Motion, J. P. M.; Kivimäe, S.; Fang, Q.; Lee, R. J. Delivery of Lipid Micelles into Infarcted Myocardium Using a Lipid-Linked Matrix Metalloproteinase Targeting Peptide. Mol. Pharm. 2015, 12, 1150–1157. DOI: https://doi.org/10.1021/mp500653y.
- Fouladi, F.; Steffen, K. J.; Mallik, S. Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs. Bioconjug. Chem. 2017, 28, 857–868. DOI: https://doi.org/10.1021/acs.bioconjchem.6b00736.
- Callmann, C. E.; Barback, C. V.; Thompson, M. P.; Hall, D. J.; Mattrey, R. F.; Gianneschi, N. C. Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors. Adv. Mater. 2015, 27, 4611–4615. DOI: https://doi.org/10.1002/adma.201501803.
- Shahriari, M.; Zahiri, M.; Abnous, K.; Taghdisi, S. M.; Ramezani, M.; Alibolandi, M. Enzyme Responsive Drug Delivery Systems in Cancer Treatment. J. Control. Release. 2019, 308, 172–189. DOI: https://doi.org/10.1016/j.jconrel.2019.07.004.
- De La Rica, R.; Aili, D.; Stevens, M. M. Enzyme-Responsive Nanoparticles for Drug Release and Diagnostics. Adv. Drug Deliv. Rev. 2012, 64, 967–978. DOI: https://doi.org/10.1016/j.addr.2012.01.002.
- Dennis, E. A. Introduction to Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease. J. Lipid Res. 2015, 56, 1245–1247. DOI: https://doi.org/10.1194/jlr.E061101.
- Vasquez, A. M.; Mouchlis, V. D.; Dennis, E. A. Review of Four Major Distinct Types of Human Phospholipase A2. Adv. Biol. Regul. 2018, 67, 212–218. DOI: https://doi.org/10.1016/j.jbior.2017.10.009.
- Yarla, N. S.; Bishayee, A.; Vadlakonda, L.; Chintala, R.; Duddukuri, G. R.; Reddanna, P.; Dowluru, K. S. V. G. K. Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases. Curr. Drug Targets. 2016, 17, 1940–1962. DOI: https://doi.org/10.2174/1389450116666150727122501.
- Andresen, T. L.; Davidsen, J.; Begtrup, M.; Mouritsen, O. G.; Jørgensen, K. Enzymatic Release of Antitumor Ether Lipids by Specific Phospholipase A2 Activation of Liposome-Forming Prodrugs. J. Med. Chem. 2004, 47, 1694–1703. DOI: https://doi.org/10.1021/jm031029r.
- Wang, C.; Chen, S.; Wang, Y.; Liu, X.; Hu, F.; Sun, J.; Yuan, H. Lipase‐Triggered Water‐Responsive “Pandora's Box” for Cancer Therapy: Toward Induced Neighboring Effect and Enhanced Drug Penetration. Adv. Mater. 2018, 30, 1706407. DOI: https://doi.org/10.1002/adma.201706407.
- Zhu, G.; Mock, J. N.; Aljuffali, I.; Cummings, B. S.; Arnold, R. D. Secretory Phospholipase A2 Responsive Liposomes. J. Pharm. Sci. 2011, 100, 3146–3159. DOI: https://doi.org/10.1002/jps.22530.
- Thamphiwatana, S.; Gao, W.; Pornpattananangkul, D.; Zhang, Q.; Fu, V.; Li, J.; Li, J.; Obonyo, M.; Zhang, L. Phospholipase A2-Responsive Antibiotic Delivery via Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection. J. Mater. Chem. B. 2014, 2, 8201–8207. DOI: https://doi.org/10.1039/C4TB01110D.
- Klein, T.; Eckhard, U.; Dufour, A.; Solis, N.; Overall, C. M. Proteolytic Cleavage-Mechanisms, Function, and "Omic" Approaches for a Near-Ubiquitous Posttranslational Modification. Chem. Rev. 2018, 118, 1137–1168. DOI: https://doi.org/10.1021/acs.chemrev.7b00120.
- Nakanishi, H. Microglial Cathepsin B as a Key Driver of Inflammatory Brain Diseases and Brain Aging. Neural Regen. Res. 2020, 15, 25–29. DOI: https://doi.org/10.4103/1673-5374.264444.
- Dheer, D.; Nicolas, J.; Shankar, R. Cathepsin-Sensitive Nanoscale Drug Delivery Systems for Cancer Therapy and Other Diseases. Adv. Drug Deliv. Rev. 2019, 151–152, 130–151. DOI: https://doi.org/10.1016/j.addr.2019.01.010.
- Olson, O. C.; Joyce, J. A. Cysteine Cathepsin Proteases: Regulators of Cancer Progression and Therapeutic Response. Nat. Rev. Cancer. 2015, 15, 712–729. DOI: https://doi.org/10.1038/nrc4027.
- Ulijn, R. V. Enzyme-Responsive Materials: A New Class of Smart Biomaterials. J. Mater. Chem. 2006, 16, 2217–2225. DOI: https://doi.org/10.1039/b601776m.
- Li, N.; Li, N.; Yi, Q.; Luo, K.; Guo, C.; Pan, D.; Gu, Z. Amphiphilic Peptide Dendritic Copolymer-Doxorubicin Nanoscale Conjugate Self-Assembled to Enzyme-Responsive Anti-Cancer Agent. Biomaterials. 2014, 35, 9529–9545. DOI: https://doi.org/10.1016/j.biomaterials.2014.07.059.
- Mondragón, L.; Mas, N.; Ferragud, V.; de la Torre, C.; Agostini, A.; Martínez‐Máñez, R.; Sancenón, F.; Amorós, P.; Pérez‐Payá, E.; Orzáez, M. Enzyme-Responsive Intracellular-Controlled Release using Silica Mesoporous Nanoparticles Capped with ε-Poly-L-Lysine. Chemistry. 2014, 20, 5271–5281. DOI: https://doi.org/10.1002/chem.201400148.
- Cheng, Y.-J.; Luo, G.-F.; Zhu, J.-Y.; Xu, X.-D.; Zeng, X.; Cheng, D.-B.; Li, Y.-M.; Wu, Y.; Zhang, X.-Z.; Zhuo, R.-X.; et al. Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles. ACS Appl. Mater. Interfaces. 2015, 7, 9078–9087. DOI: https://doi.org/10.1021/acsami.5b00752.
- Ajaj, K. A.; Biniossek, M. L.; Kratz, F. Development of Protein-Binding Bifunctional Linkers for a New Generation of Dual-Acting Prodrugs. Bioconjug. Chem. 2009, 20, 390–396. DOI: https://doi.org/10.1021/bc800429q.
- Das, S. S.; Bharadwaj, P.; Bilal, M.; Barani, M.; Rahdar, A.; Taboada, P.; Bungau, S.; Kyzas, G. Z. Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis. Polymers. 2020, 12, 1397. DOI: https://doi.org/10.3390/polym12061397.
- Yazdani, M.; Shahdadfar, A.; Jackson, C. J.; Utheim, T. P. Hyaluronan-Based Hydrogel Scaffolds for Limbal Stem Cell Transplantation: A Review. Cells. 2019, 8, 245. DOI: https://doi.org/10.3390/cells8030245.
- Kim, S. W.; Oh, K. T.; Youn, Y. S.; Lee, E. S. Hyaluronated Nanoparticles with pH-and Enzyme-Responsive Drug Release Properties. Colloids Surf. B Biointerfaces. 2014, 116, 359–364. DOI: https://doi.org/10.1016/j.colsurfb.2014.01.017.
- Dosio, F.; Arpicco, S.; Stella, B.; Fattal, E. Hyaluronic Acid for Anticancer Drug and Nucleic Acid Delivery. Adv. Drug Deliv. Rev. 2016, 97, 204–236. DOI: https://doi.org/10.1016/j.addr.2015.11.011.
- Jiang, H.; Shi, X.; Yu, X.; He, X.; An, Y.; Lu, H. Hyaluronidase Enzyme-Responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer. Pharm. Res. 2018, 35, 73. DOI: https://doi.org/10.1007/s11095-017-2302-4.
- Jiang, T.; Mo, R.; Bellotti, A.; Zhou, J.; Gu, Z. Gel–Liposome–Mediated Co-Delivery of Anticancer Membrane-Associated Proteins and Small-Molecule Drugs for Enhanced Therapeutic Efficacy. Adv. Funct. Mater. 2014, 24, 2295–2304. DOI: https://doi.org/10.1002/adfm.201303222.
- Wells, C. M.; Harris, M.; Choi, L.; Murali, V. P.; Guerra, F. D.; Jennings, J. A. Stimuli-Responsive Drug Release from Smart Polymers. Jfb. 2019, 10, 34. DOI: https://doi.org/10.3390/jfb10030034.
- Yu, Y.; Ran, Q.; Shen, X.; Zheng, H.; Cai, K. Enzyme Responsive Titanium Substrates with Antibacterial Property and Osteo/Angio-Genic Differentiation Potentials. Colloids Surf. B Biointerfaces. 2020, 185, 110592. DOI: https://doi.org/10.1016/j.colsurfb.2019.110592.
- Li, M.; Zhao, G.; Su, W.-K.; Shuai, Q. Enzyme-Responsive Nanoparticles for anti-Tumor Drug Delivery. Front. Chem. 2020, 8, 647. DOI: https://doi.org/10.3389/fchem.2020.00647.
- Rao, J.; Khan, A. Enzyme Sensitive Synthetic Polymer Micelles Based on the Azobenzene Motif. J. Am. Chem. Soc. 2013, 135, 14056–14059. DOI: https://doi.org/10.1021/ja407514z.
- Medina, S. H.; Chevliakov, M. V.; Tiruchinapally, G.; Durmaz, Y. Y.; Kuruvilla, S. P.; ElSayed, M. E. Enzyme-Activated Nanoconjugates for Tunable Release of Doxorubicin in Hepatic Cancer Cells. Biomaterials. 2013, 34, 4655–4666. DOI: https://doi.org/10.1016/j.biomaterials.2013.02.070.
- Zhang, Z.-T.; Huang-Fu, M.-Y.; Xu, W.-H.; Han, M. Stimulus-Responsive Nanoscale Delivery Systems Triggered by the Enzymes in the Tumor Microenvironment. Eur. J. Pharm. Biopharm. 2019, 137, 122–130. DOI: https://doi.org/10.1016/j.ejpb.2019.02.009.
- Zhang, J.; Chai, X.; He, X.-P.; Kim, H.-J.; Yoon, J.; Tian, H. Fluorogenic Probes for Disease-Relevant Enzymes. Chem. Soc. Rev. 2019, 48, 683–722. DOI: https://doi.org/10.1039/C7CS00907K.
- Ahmad, W.; Ijaz, B.; Shabbiri, K.; Ahmed, F.; Rehman, S. Oxidative Toxicity in Diabetes and Alzheimer’s Disease: Mechanisms behind ROS/RNS Generation. J. Biomed. Sci. 2017, 24, 76. DOI: https://doi.org/10.1186/s12929-017-0379-z.
- Gu, Z.; Aimetti, A. A.; Wang, Q.; Dang, T. T.; Zhang, Y.; Veiseh, O.; Cheng, H.; Langer, R. S.; Anderson, D. G. Injectable Nano-Network for Glucose-Mediated Insulin Delivery. ACS Nano. 2013, 7, 4194–4201. DOI: https://doi.org/10.1021/nn400630x.
- Gong, F.; Peng, X.; Luo, C.; Shen, G.; Zhao, C.; Zou, L.; Li, L.; Sang, Y.; Zhao, Y.; Zhao, X. Cathepsin B as a Potential Prognostic and Therapeutic Marker for Human Lung Squamous Cell Carcinoma. Mol. Cancer. 2013, 12, 125. DOI: https://doi.org/10.1186/1476-4598-12-125.
- Tian, B.; Chen, X.; Zhang, H.; Li, X.; Wang, J.; Han, W.; Zhang, L.-Y.; Fu, L.; Li, Y.; Nie, C.; et al. Urokinase Plasminogen Activator Secreted by Cancer-Associated Fibroblasts Induces Tumor Progression via PI3K/AKT and ERK Signaling in Esophageal Squamous Cell Carcinoma. Oncotarget. 2017, 8, 42300–42313. DOI: https://doi.org/10.18632/oncotarget.15857.
- Su, S.-C.; Lin, C.-W.; Yang, W.-E.; Fan, W.-L.; Yang, S.-F. The Urokinase-Type Plasminogen Activator (Upa) System as a Biomarker and Therapeutic Target in Human Malignancies. Expert Opin. Ther. Targets. 2016, 20, 551–566. DOI: https://doi.org/10.1517/14728222.2016.1113260.
- Basel, M. T.; Shrestha, T. B.; Troyer, D. L.; Bossmann, S. H. Protease-Sensitive, Polymer-Caged Liposomes: A Method for Making Highly Targeted Liposomes Using Triggered Release. ACS Nano. 2011, 5, 2162–2175. DOI: https://doi.org/10.1021/nn103362n.
- Zhang, B.; Zhang, Y.; Liao, Z.; Jiang, T.; Zhao, J.; Tuo, Y.; She, X.; Shen, S.; Chen, J.; Zhang, Q.; et al. UPA-Sensitive Acpp-Conjugated Nanoparticles for Multi-Targeting Therapy of Brain Glioma. Biomaterials. 2015, 36, 98–109. DOI: https://doi.org/10.1016/j.biomaterials.2014.09.008.
- Pak, C. C.; Erukulla, R. K.; Ahl, P. L.; Janoff, A. S.; Meers, P. Elastase Activated Liposomal Delivery to Nucleated Cells. Biochim. Biophys. Acta. 1999, 1419, 111–126. DOI: https://doi.org/10.1016/S0005-2736(98)00256-9.
- Pérez-Ibave, D. C.; Burciaga-Flores, C. H.; Elizondo-Riojas, M.-Á. Prostate-Specific Antigen (PSA) as a Possible Biomarker in Non-Prostatic Cancer: A Review. Cancer Epidemiol. 2018, 54, 48–55. DOI: https://doi.org/10.1016/j.canep.2018.03.009.
- Xiang, B.; Dong, D.-W.; Shi, N.-Q.; Gao, W.; Yang, Z.-Z.; Cui, Y.; Cao, D.-Y.; Qi, X.-R. PSA-Responsive and PSMA-Mediated Multifunctional Liposomes for Targeted Therapy of Prostate Cancer. Biomaterials. 2013, 34, 6976–6991. DOI: https://doi.org/10.1016/j.biomaterials.2013.05.055.
- Moradi, A.; Srinivasan, S.; Clements, J.; Batra, J. Beyond the Biomarker Role: Prostate-Specific Antigen (PSA) in the Prostate Cancer Microenvironment. Cancer Metastasis Rev. 2019, 38, 333–346. DOI: https://doi.org/10.1007/s10555-019-09815-3.
- García, C.; Hoyos, P.; Hernáiz, M. J. Enzymatic Synthesis of Carbohydrates and Glycoconjugates Using Lipases and Glycosidases in Green Solvents. Biocatal. Biotransform. 2018, 36, 131–140. DOI: https://doi.org/10.1080/10242422.2017.1349760.
- Bernardos, A.; Mondragon, L.; Aznar, E.; Marcos, M. D.; Martinez-Mañez, R.; Sancenon, F.; Soto, J.; Barat, J. M.; Perez-Paya, E.; Guillem, C.; et al. Enzyme-Responsive Intracellular Controlled Release Using Nanometric Silica Mesoporous Supports Capped with “Saccharides”. ACS Nano. 2010, 4, 6353–6368. DOI: https://doi.org/10.1021/nn101499d.
- Ruttala, H. B.; Ramasamy, T.; Madeshwaran, T.; Hiep, T. T.; Kandasamy, U.; Oh, K. T.; Choi, H.-G.; Yong, C. S.; Kim, J. O. Emerging Potential of Stimulus-Responsive Nanosized Anticancer Drug Delivery Systems for Systemic Applications. Arch. Pharm. Res. 2018, 41, 111–129. DOI: https://doi.org/10.1007/s12272-017-0995-x.
- Boehnke, N.; Maynard, H. D. Design of Modular Dual Enzyme-Responsive Peptides. Pept. Sci. 2017, 108, e23035. DOI: https://doi.org/10.1002/bip.23035.
- Radhakrishnan, K.; Tripathy, J.; Gnanadhas, D. P.; Chakravortty, D.; Raichur, A. M. Dual Enzyme Responsive and Targeted Nanocapsules for Intracellular Delivery of Anticancer Agents. RSC Adv. 2014, 4, 45961–45968. DOI: https://doi.org/10.1039/C4RA07815B.
- Kim, E.-J.; Bhuniya, S.; Lee, H.; Kim, H. M.; Cheong, C.; Maiti, S.; Hong, K. S.; Kim, J. S. An Activatable Prodrug for the Treatment of Metastatic Tumors. J. Am. Chem. Soc. 2014, 136, 13888–13894. DOI: https://doi.org/10.1021/ja5077684.
- Tao, W.; He, Z. ROS-Responsive Drug Delivery Systems for Biomedical Applications. Asian J. Pharm. Sci. 2018, 13, 101–112. DOI: https://doi.org/10.1016/j.ajps.2017.11.002.
- Han, H.; Valdepérez, D.; Jin, Q.; Yang, B.; Li, Z.; Wu, Y.; Pelaz, B.; Parak, W. J.; Ji, J. Dual Enzymatic Reaction-Assisted Gemcitabine Delivery Systems for Programmed Pancreatic Cancer Therapy. ACS Nano. 2017, 11, 1281–1291. DOI: https://doi.org/10.1021/acsnano.6b05541.
- Fiehn, C.; Kratz, F.; Sass, G.; Müller-Ladner, U.; Neumann, E. Targeted Drug Delivery by in Vivo Coupling to Endogenous Albumin: An Albumin-Binding Prodrug of Methotrexate (MTX) is Better than MTX in the Treatment of Murine Collagen-Induced Arthritis. Ann. Rheum. Dis. 2008, 67, 1188–1191. DOI: https://doi.org/10.1136/ard.2007.086843.
- Xu, J.-H.; Gao, F.-P.; Li, L.-L.; Ma, H. L.; Fan, Y.-S.; Liu, W.; Guo, S.-S.; Zhao, X.-Z.; Wang, H. Gelatin–Mesoporous Silica Nanoparticles as Matrix Metalloproteinases-Degradable Drug Delivery Systems in Vivo. Micropor. Mesopor. Mater. 2013, 182, 165–172. DOI: https://doi.org/10.1016/j.micromeso.2013.08.050.
- Zhang, X.; Wang, X.; Zhong, W.; Ren, X.; Sha, X.; Fang, X. Matrix Metalloproteinases-2/9-Sensitive Peptide-Conjugated Polymer Micelles for Site-Specific Release of Drugs and Enhancing Tumor Accumulation: Preparation and in Vitro and in Vivo Evaluation. Int. J. Nanomed. 2016, 11, 1643–1661.
- Mi, Y.; Wolfram, J.; Mu, C.; Liu, X.; Blanco, E.; Shen, H.; Ferrari, M. Enzyme-Responsive Multistage Vector for Drug Delivery to Tumor Tissue. Pharmacol. Res. 2016, 113, 92–99. DOI: https://doi.org/10.1016/j.phrs.2016.08.024.
- van Rijt, S. H.; Bölükbas, D. A.; Argyo, C.; Datz, S.; Lindner, M.; Eickelberg, O.; Königshoff, M.; Bein, T.; Meiners, S. Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to Ex Vivo Human and Mouse Lung Tumors. ACS Nano. 2015, 9, 2377–2389. DOI: https://doi.org/10.1021/nn5070343.
- Li, H.; Miteva, M.; Kirkbride, K. C.; Cheng, M. J.; Nelson, C. E.; Simpson, E. M.; Gupta, M. K.; Duvall, C. L.; Giorgio, T. D. Dual MMP7-Proximity-Activated and Folate Receptor-Targeted Nanoparticles for siRNA Delivery. Biomacromolecules. 2015, 16, 192–201. DOI: https://doi.org/10.1021/bm501394m.
- Han, M.; Huang-Fu, M.-Y.; Guo, W.-W.; Guo, N.-N.; Chen, J.; Liu, H.-N.; Xie, Z.-Q.; Lin, M.-T.; Wei, Q.-C.; Gao, J.-Q. MMP-2-Sensitive HA End-Conjugated Poly (Amidoamine) Dendrimers via Click Reaction to Enhance Drug Penetration into Solid Tumor. ACS Appl. Mater. Interfaces. 2017, 9, 42459–42470. DOI: https://doi.org/10.1021/acsami.7b10098.
- Yang, Y.; Aw, J.; Chen, K.; Liu, F.; Padmanabhan, P.; Hou, Y.; Cheng, Z.; Xing, B. Enzyme-Responsive Multifunctional Magnetic Nanoparticles for Tumor Intracellular Drug Delivery and Imaging. Chem. Asian J. 2011, 6, 1381–1389. DOI: https://doi.org/10.1002/asia.201000905.
- Cai, H.; Wang, X.; Zhang, H.; Sun, L.; Pan, D.; Gong, Q.; Gu, Z.; Luo, K. Enzyme-Sensitive Biodegradable and Multifunctional Polymeric Conjugate as Theranostic Nanomedicine. Appl. Mater. Today. 2018, 11, 207–218. DOI: https://doi.org/10.1016/j.apmt.2018.02.003.
- Jin, Y.; Yang, F.; Du, L. Nanoassemblies Containing a Fluorouracil/Zidovudine Glyceryl Prodrug with Phospholipase A2-Triggered Drug Release for Cancer Treatment. Colloids Surf. B Biointerfaces. 2013, 112, 421–428. DOI: https://doi.org/10.1016/j.colsurfb.2013.08.021.
- Popat, A.; Ross, B. P.; Liu, J.; Jambhrunkar, S.; Kleitz, F.; Qiao, S. Z. Enzyme-Responsive Controlled Release of Covalently Bound Prodrug from Functional Mesoporous Silica Nanospheres. Angew. Chem. Int. Ed. Engl. 2012, 51, 12486–12489. DOI: https://doi.org/10.1002/anie.201206416.
- Sharma, A.; Kim, E.-J.; Shi, H.; Lee, J. Y.; Chung, B. G.; Kim, J. S. Development of a Theranostic Prodrug for Colon Cancer Therapy by Combining Ligand-Targeted Delivery and Enzyme-Stimulated Activation. Biomaterials. 2018, 155, 145–151. DOI: https://doi.org/10.1016/j.biomaterials.2017.11.019.
- Baier, G.; Cavallaro, A.; Vasilev, K.; Mailänder, V.; Musyanovych, A.; Landfester, K. Enzyme Responsive Hyaluronic Acid Nanocapsules Containing Polyhexanide and Their Exposure to Bacteria to Prevent Infection. Biomacromolecules. 2013, 14, 1103–1112. DOI: https://doi.org/10.1021/bm302003m.
- Chen, Z.; Li, Z.; Lin, Y.; Yin, M.; Ren, J.; Qu, X. Bioresponsive Hyaluronic Acid-Capped Mesoporous Silica Nanoparticles for Targeted Drug Delivery. Chem. Eur. J. 2013, 19, 1778–1783. DOI: https://doi.org/10.1002/chem.201202038.
- Vandooren, J.; Opdenakker, G.; Loadman, P. M.; Edwards, D. R. Proteases in Cancer Drug Delivery. Adv. Drug Deliv. Rev. 2016, 97, 144–155. DOI: https://doi.org/10.1016/j.addr.2015.12.020.
- Denmeade, S. R.; Jakobsen, C. M.; Janssen, S.; Khan, S. R.; Garrett, E. S.; Lilja, H.; Christensen, S. B.; Isaacs, J. T. Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer. J. Natl. Cancer Inst. 2003, 95, 990–1000.